Literature DB >> 12540491

Antisense oligodeoxynucleotides decrease LGL1 mRNA and protein levels and inhibit branching morphogenesis in fetal rat lung.

Lami Oyewumi1, Feige Kaplan, Stéphane Gagnon, Neil B Sweezey.   

Abstract

We previously described the cloning of the late gestation lung 1 gene (LGL1), a novel glucocorticoid-inducible gene expressed in the mesenchyme of fetal lung. We report here evidence for a role of the LGL1 gene product (lgl1) in fetal rat lung airway branching morphogenesis, temporal and spatial localization of LGL1 mRNA and lgl1 protein in fetal rat lung, and a correction of the previously published LGL1 sequence. Both the mRNA and protein were detected during fetal lung development. LGL1 mRNA was detected from gestational Day 12 by reverse transcriptase-polymerase chain reaction, and from Day 13 by in situ hybridization. lgl1 protein was detected from Day 18 by Western analysis and from Day 16 by immunohistochemistry. The types of cells expressing LGL1 mRNA and lgl1 protein were assessed by immunohistochemical staining of adjacent serial tissue sections for markers of mesenchymal (vimentin) and smooth muscle (alpha-actin) cells. As gestation advanced, increasing amounts of mRNA and protein were expressed in these cells. In support of a role for lgl1 in airway branching morphogenesis, antisense (but neither sense nor scrambled) oligodeoxynucleotides directed against LGL1 inhibited airway branching in fetal rat lung buds in explant culture, in a dose- and time-dependent manner. The levels of lgl1 protein and LGL1 mRNA expression were decreased in those explants that had inhibited airway branching, compared with the uninhibited controls. Our findings suggest that lgl1 plays an important role in fetal airway branching morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540491     DOI: 10.1165/rcmb.4877

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  14 in total

1.  Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma.

Authors:  Priyadarshini Kachroo; Julian Hecker; Bo L Chawes; Tarunveer S Ahluwalia; Michael H Cho; Dandi Qiao; Rachel S Kelly; Su H Chu; Yamini V Virkud; Mengna Huang; Kathleen C Barnes; Esteban G Burchard; Celeste Eng; Donglei Hu; Juan C Celedón; Michelle Daya; Albert M Levin; Hongsheng Gui; L Keoki Williams; Erick Forno; Angel C Y Mak; Lydiana Avila; Manuel E Soto-Quiros; Michelle M Cloutier; Edna Acosta-Pérez; Glorisa Canino; Klaus Bønnelykke; Hans Bisgaard; Benjamin A Raby; Christoph Lange; Scott T Weiss; Jessica A Lasky-Su
Journal:  Chest       Date:  2019-09-23       Impact factor: 9.410

2.  Fetal tracheal occlusion for the treatment of congenital diaphragmatic hernia.

Authors:  Jean-Martin Laberge
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

3.  Prenatal retinoic acid treatment upregulates late gestation lung protein 1 in the nitrofen-induced hypoplastic lung in late gestation.

Authors:  Elke Maria Ruttenstock; Takashi Doi; Jens Dingemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

4.  Modulation of Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during alveolarization.

Authors:  Katia Nadeau; Laura Montermini; Isabel Mandeville; Mousheng Xu; Scott T Weiss; Neil B Sweezey; Feige Kaplan
Journal:  Pediatr Res       Date:  2010-04       Impact factor: 3.756

5.  Lgl1, a mesenchymal modulator of early lung branching morphogenesis, is a secreted glycoprotein imported by late gestation lung epithelial cells.

Authors:  Lami Oyewumi; Feige Kaplan; Neil B Sweezey
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

6.  Reduced viability of mice with lung epithelial-specific knockout of glucocorticoid receptor.

Authors:  Neetu Manwani; Stéphane Gagnon; Martin Post; Stephen Joza; Louis Muglia; Salomon Cornejo; Feige Kaplan; Neil B Sweezey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-30       Impact factor: 6.914

7.  CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.

Authors:  Tao Wang; Zhi-qin Wang; Lv Wang; Li Yan; Jian Wan; Sheng Zhang; Hong-quan Jiang; Wen-fang Li; Zhao-fen Lin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells.

Authors:  Blanca E Himes; Xiaofeng Jiang; Peter Wagner; Ruoxi Hu; Qiyu Wang; Barbara Klanderman; Reid M Whitaker; Qingling Duan; Jessica Lasky-Su; Christina Nikolos; William Jester; Martin Johnson; Reynold A Panettieri; Kelan G Tantisira; Scott T Weiss; Quan Lu
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

9.  CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Authors:  Jung-Yoon Yoo; Heesung Shin; Tae Hoon Kim; Won-Seok Choi; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Un-Hwan Ha; Jae-Wook Jeong
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

10.  Inflammatory cytokines, goblet cell hyperplasia and altered lung mechanics in Lgl1+/- mice.

Authors:  Jie Lan; Leslie Ribeiro; Isabel Mandeville; Katia Nadeau; Tim Bao; Salomon Cornejo; Neil B Sweezey; Feige Kaplan
Journal:  Respir Res       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.